English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

primary and 406 (36%) were secondary in which the patient had one or more previous breast augmentation procedures. Silicone gel implants were utilized in 471 (65%) of the primary and 324 (80%) of the secondary procedures. Operative technique involved a circumvertical or inverted-T mastopexy in 77% (n= 871) and a bilateral mastopexy in 93% of patients. The overall reoperation rate was 14.9% (13.2% of primary and 16.6% of secondary procedures) over a mean followup period of 43 months (range 4 months to 121 months). Tissue related complications consisting of recurrent or persistent ptosis and poor scaring were most common at 6.2% (n= 71). Implant related complications requiring a revision were most commonly a result of the patient’s desire to change implant size 3.1% (n=36) and capsular contracture Baker III/IV in 2.8% (n= 32). There were no cases of periprosthetic infection requiring explantation and no significant skin flap necrosis (> 2cm) or nipple areolar loss noted.

Abstract: Validation of a CD30 ELISA for the Rapid Detection of Breast Implant Associated Anaplastic Large Cell Lymphoma